APA (7th ed.) Citation

Loesche, C., Picard, D., Van Hoorick, B., Schuhmann, I., Jäger, P., Klein, K., . . . Röhn, T. A. (2024). LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial. CTS: Clinical & Translational Science, 17(2), 1. https://doi.org/10.1111/cts.13724

Chicago Style (17th ed.) Citation

Loesche, Christian, et al. "LTA4H Inhibitor LYS006: Clinical PK/PD and Safety in a Randomized Phase I Clinical Trial." CTS: Clinical & Translational Science 17, no. 2 (2024): 1. https://doi.org/10.1111/cts.13724.

MLA (9th ed.) Citation

Loesche, Christian, et al. "LTA4H Inhibitor LYS006: Clinical PK/PD and Safety in a Randomized Phase I Clinical Trial." CTS: Clinical & Translational Science, vol. 17, no. 2, 2024, p. 1, https://doi.org/10.1111/cts.13724.